Cart
sales@molnova.com
CPDA
CAS No. 1415834-63-7
CPDA( —— )
Catalog No. M26128 CAS No. 1415834-63-7
CPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 79 | Get Quote |
|
| 10MG | 125 | Get Quote |
|
| 25MG | 251 | Get Quote |
|
| 50MG | 475 | Get Quote |
|
| 100MG | 692 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCPDA
-
NoteResearch use only, not for human use.
-
Brief DescriptionCPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2).
-
DescriptionCPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2).(In Vitro):CPDA enhances insulin signaling.(In Vivo):CPDA greatly improves abnormal glucose metabolism in diabetic animals. In db/db mice, CPDA improves abnormal glucose metabolism.
-
In VitroCPDA enhances insulin signaling.
-
In VivoCPDA greatly improves abnormal glucose metabolism in diabetic animals. CPDA improves the abnormal glucose metabolism in db/db mice.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorSmoothened
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1415834-63-7
-
Formula Weight388.8
-
Molecular FormulaC20H15ClF2N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 50 mg/mL (128.60 mM)
-
SMILESFc1cccc(F)c1CC(=O)Nc1cc(OCc2ccc(Cl)cc2)ccn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Solinas et al (2012) Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity. J.Med.Chem. 55 1559
molnova catalog
related products
-
Talabostat mesylate
Talabostat mesylate is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast activation protein.
-
Ertiprotafib
Ertiprotafib (PTP 112), a selective and potent inhibitor of protein tyrosine phosphate 1B (PTP1B) and IkappaB kinase β (IKK-β), is a novel insulin sensitizer with potential anticancer activity for the study of type 2 diabetes and breast cancer.
-
PTP1B-IN-3
PTP1B-IN-3 is a selective and potent PTP1B inhibitor with anticancer activity that inhibits PTP1B and TCPTP.PTP1B-IN-3 is used in the study of diabetes.
